November 2025 - Corcept Therapeutics

Miricorilant, a Selective Glucocorticoid Receptor Modulator, Reprograms Hepatic Gene Networks in Metabolic Dysfunction–Associated Steatohepatitis

November 7, 2025

Mayoral Monibas, et al. • 2025 • AASLD 2025

Phase 3 ROSELLA (GOG-3073, ENGOT-ov72) Trial of Relacorilant + Nab-paclitaxel vs Nab-paclitaxel in Platinum-resistant Ovarian Cancer: Primary Results and Outcomes in Older Patients

November 4, 2025

Olawaiye et al. • 2025 • IGCS